Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China. Zhao L, Du H, Alamgir M, Yang J, et al. Eur J Dermatol 2020;30:738-740.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao L, Du H, Alamgir M, Yang J, et al. Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China. Eur J Dermatol 2020;30:738-740.
PMID: 33459264